| Lisa H Freeland, CNM | |
|
3919 N Maple St, Spokane, WA 99205-1349 | |
| (509) 444-8200 | |
| (509) 444-7806 |
| Full Name | Lisa H Freeland |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 31 Years |
| Location | 3919 N Maple St, Spokane, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013952571 | NPI | - | NPPES |
| G8908948 | Other | WA | MEDICARE PTAN |
| AP60210579 | Other | WA | ADVANCED REGISTERED NURSE PRACTIONER |
| 6836 | Other | WA | CNM |
| 1013952571 | Medicaid | WA | |
| RN60210577 | Other | WA | REGISTERED NURSE |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Health Association Of Spokane | 9638063217 | 156 |
News Archive
A new study shows an "alarming rise" over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University and Oregon State University.
As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years.
Each year, thousands of Canadians are given the news: they have skin cancer. It is the most common form of cancer in Canada and around the world, but if detected early, survival rates are extremely high. According to Liam Rourke, it doesn't happen nearly as often as it could.
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
NT-MDT S&L (Ireland) is working in collaboration with the University of Limerick (UL) and a number of other Universities across Europe to develop an instrument, which will be capable of screening patients cells for Alzheimer's disease.
› Verified 2 days ago
| Entity Name | Community Health Association Of Spokane |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326005851 PECOS PAC ID: 9638063217 Enrollment ID: O20040212000971 |
News Archive
A new study shows an "alarming rise" over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University and Oregon State University.
As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years.
Each year, thousands of Canadians are given the news: they have skin cancer. It is the most common form of cancer in Canada and around the world, but if detected early, survival rates are extremely high. According to Liam Rourke, it doesn't happen nearly as often as it could.
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
NT-MDT S&L (Ireland) is working in collaboration with the University of Limerick (UL) and a number of other Universities across Europe to develop an instrument, which will be capable of screening patients cells for Alzheimer's disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa H Freeland, CNM 611 N Iron Bridge Way, Spokane, WA 99202-4932 Ph: (509) 444-8888 | Lisa H Freeland, CNM 3919 N Maple St, Spokane, WA 99205-1349 Ph: (509) 444-8200 |
News Archive
A new study shows an "alarming rise" over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University and Oregon State University.
As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years.
Each year, thousands of Canadians are given the news: they have skin cancer. It is the most common form of cancer in Canada and around the world, but if detected early, survival rates are extremely high. According to Liam Rourke, it doesn't happen nearly as often as it could.
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
NT-MDT S&L (Ireland) is working in collaboration with the University of Limerick (UL) and a number of other Universities across Europe to develop an instrument, which will be capable of screening patients cells for Alzheimer's disease.
› Verified 2 days ago
Katie L Gomez, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1101 W College Ave, Spokane, WA 99201 Phone: 509-324-1420 | |
Kristin Walters, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 122 W 7th Ave, Suite 450, Spokane, WA 99204 Phone: 509-455-8820 | |
Anna Denton, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5633 N Lidgerwood St, Spokane, WA 99208 Phone: 509-482-0111 Fax: 509-482-2133 | |
Michael Colver, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3919 N Maple St, Spokane, WA 99205 Phone: 509-444-8200 Fax: 509-444-7806 | |
Heidi A Weitzel, LPN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 44 E Cozza Dr, Spokane, WA 99208 Phone: 509-325-6800 | |
Brittanee R Worthy, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 220 E Rowan Ave Ste 300, Spokane, WA 99207 Phone: 509-489-3554 Fax: 509-489-3558 | |
Diane C Beernink, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5921 M Market St, Spokane, WA 99208 Phone: 509-487-1604 Fax: 509-482-6286 |